Praxis Precision Medicines, Inc.
Price Action
Technical Summary
EMERGING TRENDPraxis Precision Medicines, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings growth of 3% provides fundamental context to the price action. Investors should exercise caution due to high volatility (78% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $289.05 | +4.83% | ABOVE |
| 50 SMA | $315.67 | -4.01% | BELOW |
| 100 SMA | $314.97 | -3.80% | BELOW |
| 150 SMA | $294.93 | +2.74% | ABOVE |
| 200 SMA | $246.58 | +22.88% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PRAX in an uptrend right now?
PRAX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is PRAX overbought or oversold?
PRAX's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is PRAX outperforming the market?
PRAX has a Relative Strength (RS) Rating of 94 out of 99. Yes, PRAX is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is PRAX in its 52-week range?
PRAX is trading at $303.00, which is 83% of its 52-week high ($366.52) and 81% above its 52-week low ($37.19).
How volatile is PRAX?
PRAX has a Beta of 1.49 and 52-week volatility of 78%. It's more volatile than the S&P 500 - expect bigger swings.